MX2017007905A - Metodos para aumentar el factor de crecimiento insulinico 1 (igf-1) en suero en un animal. - Google Patents
Metodos para aumentar el factor de crecimiento insulinico 1 (igf-1) en suero en un animal.Info
- Publication number
- MX2017007905A MX2017007905A MX2017007905A MX2017007905A MX2017007905A MX 2017007905 A MX2017007905 A MX 2017007905A MX 2017007905 A MX2017007905 A MX 2017007905A MX 2017007905 A MX2017007905 A MX 2017007905A MX 2017007905 A MX2017007905 A MX 2017007905A
- Authority
- MX
- Mexico
- Prior art keywords
- subject
- increased
- methods
- igf
- growth
- Prior art date
Links
- 210000002966 serum Anatomy 0.000 title abstract 3
- 101150088952 IGF1 gene Proteins 0.000 title 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 abstract 6
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 abstract 3
- 102000013275 Somatomedins Human genes 0.000 abstract 3
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 206010021143 Hypoxia Diseases 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 241000282849 Ruminantia Species 0.000 abstract 1
- 206010042573 Superovulation Diseases 0.000 abstract 1
- 208000029028 brain injury Diseases 0.000 abstract 1
- 206010016165 failure to thrive Diseases 0.000 abstract 1
- 230000004720 fertilization Effects 0.000 abstract 1
- 210000001161 mammalian embryo Anatomy 0.000 abstract 1
- 239000008267 milk Substances 0.000 abstract 1
- 210000004080 milk Anatomy 0.000 abstract 1
- 235000013336 milk Nutrition 0.000 abstract 1
- 208000005264 motor neuron disease Diseases 0.000 abstract 1
- 208000010125 myocardial infarction Diseases 0.000 abstract 1
- 210000000287 oocyte Anatomy 0.000 abstract 1
- 210000002027 skeletal muscle Anatomy 0.000 abstract 1
- 230000035899 viability Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Microbiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
En la presente hay métodos para aumentar la concentración del factor de crecimiento insulínico (IGF) en el suero de un sujeto. En una modalidad, el método incluye administrar IGF-1 activo a un sujeto, donde aumenta la concentración de IGF en el suero del sujeto. También se proporcionan métodos para tratar una afección en un sujeto, métodos para mejorar o mantener la salud de un sujeto y métodos para mejorar una característica de un sujeto. Los ejemplos de afecciones incluyen un trastorno de la neurona motora, enfermedad de Alzheimer, infarto de miocardio, lesión cerebral hipóxica-isquémica, osteoporosis, reparación del músculo esquelético e insuficiencia de crecimiento. Los ejemplos de características incluyen aumento de la producción de leche, aumento de la fertilización, aumento de la reproducción, aumento del crecimiento, aumento de la calidad de oocitos en un rumiante sometido a la superovulación y aumento de viabilidad del embrión. En una modalidad, el IGF-1 administrado al sujeto se obtiene de una fuente natural que se ha procesado para aumentar la cantidad de IGF-1 activo.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462092340P | 2014-12-16 | 2014-12-16 | |
| PCT/US2015/066119 WO2016100528A1 (en) | 2014-12-16 | 2015-12-16 | Methods for increasing serum igf-1 in an animal |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2017007905A true MX2017007905A (es) | 2017-09-05 |
Family
ID=56127546
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017007905A MX2017007905A (es) | 2014-12-16 | 2015-12-16 | Metodos para aumentar el factor de crecimiento insulinico 1 (igf-1) en suero en un animal. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20170368149A1 (es) |
| EP (1) | EP3233109A4 (es) |
| KR (1) | KR20170094238A (es) |
| CN (1) | CN107106661A (es) |
| BR (1) | BR112017012792A2 (es) |
| CA (1) | CA2970539A1 (es) |
| MX (1) | MX2017007905A (es) |
| WO (1) | WO2016100528A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111195350A (zh) * | 2020-01-15 | 2020-05-26 | 重庆大学 | IGF1和IGF1Ec24联合在制备促进组织修复与再生的药物中的应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06510065A (ja) * | 1992-06-08 | 1994-11-10 | カイロン コーポレーション | 成長因子ｉｇｆ−ｉおよび／またはｉｇｆ−ｉｉの用法 |
| AUPP327198A0 (en) * | 1998-04-30 | 1998-05-21 | Northfield Laboratories Pty Ltd | A food composition and method of using same |
| US6677500B2 (en) * | 2000-08-15 | 2004-01-13 | Board Of Trustees Of The University Of Illinois | Ungulates expressing exogenous IGF-I in their milk |
| WO2005020898A2 (en) * | 2003-08-21 | 2005-03-10 | Tercica, Inc. | Methods of reducing visceral fat by increasing levels of insulin-like growth factor-i (igf-i) |
| HUE027218T2 (en) * | 2003-09-12 | 2016-10-28 | Ipsen Biopharmaceuticals Inc | Methods for Treatment of IGF-1 (Insulin-like Growth Factor 1) Deficiency |
| CN1938018B (zh) * | 2003-10-03 | 2010-09-01 | 维伊林股份有限公司 | 化合物在制备治疗与降低的igf-1血清水平有关的人和动物的各种疾病状况的组合物中的用途 |
| EP1667678B1 (en) * | 2003-10-03 | 2009-05-06 | Veijlen N.V. | Animal feed composition |
| ES2532089T3 (es) * | 2005-06-02 | 2015-03-24 | Ipsen Biopharmaceuticals, Inc. | GH e IGF-1 para el tratamiento de trastornos del crecimiento |
| ITMI20052204A1 (it) * | 2005-11-18 | 2007-05-19 | Umberto Cornelli | Uso di colostro per la profilassi delle sindroni influenzali |
| AR066354A1 (es) * | 2007-05-01 | 2009-08-12 | Genzyme Corp | La terapia sistematica con factor-1 de crecimiento de tipo insulina reduce la neuropatia periferica diabetica y mejora la funcion renal en la nefropatia diabetica |
| US20130345113A1 (en) * | 2011-07-13 | 2013-12-26 | Ronald E. Strohbehn | Method of Use of Activated Functional Proteins to Improve Animal Health |
| US20140363421A1 (en) * | 2013-06-07 | 2014-12-11 | Isatori, Inc. | Bio-active peptide supplement |
| KR102313381B1 (ko) * | 2013-12-19 | 2021-10-14 | 퓨어테인 바이오사이언스, 엘엘씨. | 동물을 치료하기 위한 방법 |
| BR112017016381A2 (pt) * | 2015-02-04 | 2018-03-27 | Puretein Bioscience Llc | métodos para aumentar características de desempenho em proles |
-
2015
- 2015-12-16 KR KR1020177016993A patent/KR20170094238A/ko not_active Withdrawn
- 2015-12-16 BR BR112017012792A patent/BR112017012792A2/pt not_active Application Discontinuation
- 2015-12-16 CN CN201580069095.5A patent/CN107106661A/zh active Pending
- 2015-12-16 WO PCT/US2015/066119 patent/WO2016100528A1/en not_active Ceased
- 2015-12-16 US US15/535,781 patent/US20170368149A1/en not_active Abandoned
- 2015-12-16 EP EP15870995.6A patent/EP3233109A4/en not_active Withdrawn
- 2015-12-16 CA CA2970539A patent/CA2970539A1/en active Pending
- 2015-12-16 MX MX2017007905A patent/MX2017007905A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN107106661A (zh) | 2017-08-29 |
| EP3233109A4 (en) | 2018-07-18 |
| BR112017012792A2 (pt) | 2018-01-02 |
| KR20170094238A (ko) | 2017-08-17 |
| CA2970539A1 (en) | 2016-06-23 |
| US20170368149A1 (en) | 2017-12-28 |
| EP3233109A1 (en) | 2017-10-25 |
| WO2016100528A1 (en) | 2016-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ruffino et al. | Neural plasticity during motor learning with motor imagery practice: Review and perspectives | |
| Dubińska-Magiera et al. | Contribution of small heat shock proteins to muscle development and function | |
| Ayadi et al. | Factors affecting milk yield, composition and udder health of Najdi ewes | |
| Singh et al. | Effect of area specific mineral mixture feeding on milk yield and composition of dairy animals of central zone of Punjab | |
| MX2017007816A (es) | Proceso para mejorar porciones y productos musculares. | |
| BR112013020802A2 (pt) | métodos e composições para tratar, reduzir ou impedir dano ao sistema nervoso de animais | |
| EP4574207A3 (en) | Means and methods for treating copper-related diseases | |
| WO2020142740A8 (en) | Treatment of sjogren's disease with nuclease fusion proteins | |
| MX2017007905A (es) | Metodos para aumentar el factor de crecimiento insulinico 1 (igf-1) en suero en un animal. | |
| PH12014500077A1 (en) | Method of use of activated functional proteins to improve animal health | |
| PH12017500998A1 (en) | Treatment of ocular conditions using progenitor cells | |
| IL290195A (en) | A method for treating Alzheimer's disease by regulating amino acid levels | |
| NZ751138A (en) | Use of human milk oligosaccharides in calves fattening | |
| BR112017010996A2 (pt) | eficiência de produção de leite aperfeiçoada em vacas leiteiras | |
| CL2016002124A1 (es) | Composiciones y metodos para mejorar la calidad de la semilla | |
| SG11201807448WA (en) | Non-human animals exhibiting degenerative symptom attributed to protein aggregation | |
| Soni et al. | Epidemiological and clinico-therapeutic studies in hypogalactic buffaloes | |
| RU2011112531A (ru) | Способ содержания пчел | |
| Prakash et al. | Empowering Dairy Farmers by Application of Modern Innovative Technologies in Milk Supply Management: A Case Study | |
| Soca et al. | Effects of body condition score at calving on metabolic state of beef cows grazing native pasture | |
| Vieira et al. | Growth performance of feedlot-finished beef cattle of different genetic groups | |
| Ivanova et al. | Milk yield, physicochemical properties and fatty acid composition of milk from sheep of the synthetic population Bulgarian dairy breed | |
| Assan | Factors affecting yield and milk composition in dairy animals | |
| Kassab et al. | Performance of three broiler hybrids feeding ditary with animal or vegetable protein resource: 1. some prodution traits | |
| Khoo | Effect of mindfulness-based stress reduction on the brain in breast cancer survivors with chronic neuropathic pain |